To characterize the molecular heterogeneity among the four genomic subtypes of cutaneous melanomas, the co-occurrence of CCND1 amplification with major driver mutations (BRAF V600, NRAS, NF1, and KIT) was analyzed in the three cohorts. This evidence concerns the gene NRAS and cutaneous melanoma.